BenedictRHZivadinovR. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol2011; 7(6): 332–342.
2.
National Institute for Health and Care Excellence (NICE). Multiple sclerosis in adults: Management (CG186). London: NICE, 2014.
3.
RoccaMAAmatoMPDe StefanoN. MAGNIMS Study Group. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol2015; 14(3): 302–317.
4.
RomeroKShammiPFeinsteinA. Neurologists’ accuracy in predicting cognitive impairment in multiple sclerosis. Mult Scler Relat Disord2015; 4(4): 291–295.
5.
LangdonDWAmatoMPBoringaJ. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler2012; 18(6): 891–898.
GoveroverYChiaravallotiNDeLucaJ. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and performance of everyday life tasks: Actual reality. Mult Scler2016; 22(4): 544–550.
8.
BenedictRHDrakeASIrwinLN. Benchmarks of meaningful impairment on the MSFC and BICAMS. Mult Scler. Epub ahead of print 26February2016. DOI: 10.1177/1352458516633517.
9.
BenedictRHAmatoMPBoringaJ. Brief International Cognitive Assessment for MS (BICAMS): International standards for validation. BMC Neurol2012; 12: 55.